JP2019532261A5 - - Google Patents

Download PDF

Info

Publication number
JP2019532261A5
JP2019532261A5 JP2019505476A JP2019505476A JP2019532261A5 JP 2019532261 A5 JP2019532261 A5 JP 2019532261A5 JP 2019505476 A JP2019505476 A JP 2019505476A JP 2019505476 A JP2019505476 A JP 2019505476A JP 2019532261 A5 JP2019532261 A5 JP 2019532261A5
Authority
JP
Japan
Prior art keywords
biomarkers
pregnant woman
preterm birth
group
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2019505476A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019532261A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/045576 external-priority patent/WO2018027171A1/en
Publication of JP2019532261A publication Critical patent/JP2019532261A/ja
Publication of JP2019532261A5 publication Critical patent/JP2019532261A5/ja
Priority to JP2022113886A priority Critical patent/JP2022140511A/ja
Withdrawn legal-status Critical Current

Links

JP2019505476A 2016-08-05 2017-08-04 予定日前の早期破水対特発性自然陣痛に起因する早産を予測するためのバイオマーカー Withdrawn JP2019532261A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022113886A JP2022140511A (ja) 2016-08-05 2022-07-15 予定日前の早期破水対特発性自然陣痛に起因する早産を予測するためのバイオマーカー

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662371666P 2016-08-05 2016-08-05
US62/371,666 2016-08-05
US201762449862P 2017-01-24 2017-01-24
US62/449,862 2017-01-24
PCT/US2017/045576 WO2018027171A1 (en) 2016-08-05 2017-08-04 Biomarkers for predicting preterm birth due to preterm premature rupture of membranes versus idiopathic spontaneous labor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022113886A Division JP2022140511A (ja) 2016-08-05 2022-07-15 予定日前の早期破水対特発性自然陣痛に起因する早産を予測するためのバイオマーカー

Publications (2)

Publication Number Publication Date
JP2019532261A JP2019532261A (ja) 2019-11-07
JP2019532261A5 true JP2019532261A5 (enExample) 2020-09-10

Family

ID=61073085

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019505476A Withdrawn JP2019532261A (ja) 2016-08-05 2017-08-04 予定日前の早期破水対特発性自然陣痛に起因する早産を予測するためのバイオマーカー
JP2022113886A Pending JP2022140511A (ja) 2016-08-05 2022-07-15 予定日前の早期破水対特発性自然陣痛に起因する早産を予測するためのバイオマーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022113886A Pending JP2022140511A (ja) 2016-08-05 2022-07-15 予定日前の早期破水対特発性自然陣痛に起因する早産を予測するためのバイオマーカー

Country Status (10)

Country Link
US (3) US20180172698A1 (enExample)
EP (1) EP3494233A4 (enExample)
JP (2) JP2019532261A (enExample)
KR (1) KR20190046825A (enExample)
CN (1) CN110191963A (enExample)
AU (1) AU2017307584A1 (enExample)
CA (1) CA3032754A1 (enExample)
IL (1) IL264576A (enExample)
RU (1) RU2019105691A (enExample)
WO (1) WO2018027171A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL256399B (en) 2015-06-19 2022-09-01 Sera Prognostics Inc Biomarker pairs for predicting preterm birth
WO2019036032A1 (en) * 2017-08-18 2019-02-21 Sera Prognostics, Inc PREGNANCY CLOCK PROTEINS FOR PREDICTING THE DATE AND MOMENT OF BIRTH
AU2018357888A1 (en) * 2017-10-30 2020-05-28 Carmentix Pte. Ltd. Biomarkers of preterm birth
CA3186291A1 (en) * 2020-06-10 2021-12-16 Board Of Regents, The University Of Texas System Method for determining risk of pre-term birth
US20240013925A1 (en) * 2020-11-05 2024-01-11 Board Of Regents, The University Of Texas System Individual optimal mode of delivery
CA3220282A1 (en) * 2021-05-21 2022-11-24 Sera Prognostics, Inc. Biomarker pairs and triplets for predicting preterm birth
RU2763707C1 (ru) * 2021-06-01 2021-12-30 Наталья Борисовна Кузнецова Способ прогнозирования преждевременного разрыва плодных оболочек в сроке от 22 до 28 недель беременности
WO2023023475A1 (en) * 2021-08-17 2023-02-23 Birth Model, Inc. Predicting time to vaginal delivery
CN118056016A (zh) * 2021-12-08 2024-05-17 深圳华大基因股份有限公司 基因标志物在预测孕妇早产风险中的应用
WO2024156709A1 (en) * 2023-01-24 2024-08-02 Université Clermont Auvergne Evaluation of serum cx3cl1 for the prediction of preterm premature rupture of membranes
WO2024182491A1 (en) * 2023-02-28 2024-09-06 Virginia Commonwealth University Polygenic risk estimator for cervical length change during pregnancy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050233400A1 (en) * 2004-03-03 2005-10-20 Weiner Carl P Proteomic method for predicting success of rescue cerclage
RU2586412C2 (ru) * 2012-06-09 2016-06-10 Общество с ограниченной ответственностью научно-технический центр "БиоКлиникум" (ООО НТЦ "БиоКлиникум") Способ оценки риска возникновения патологии беременности
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
US20160003837A1 (en) * 2013-01-08 2016-01-07 Duke University Biomarkers for the prediction of preterm birth
AU2014227891A1 (en) * 2013-03-15 2015-10-08 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
US20140287948A1 (en) * 2013-03-15 2014-09-25 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
CA3210007A1 (en) * 2013-03-15 2014-09-18 Sera Prognostics, Inc Biomarkers and methods for predicting preeclampsia
IL256399B (en) * 2015-06-19 2022-09-01 Sera Prognostics Inc Biomarker pairs for predicting preterm birth

Similar Documents

Publication Publication Date Title
JP2019532261A5 (enExample)
RU2019105691A (ru) Биомаркеры для прогнозирования преждевременных родов из-за преждевременного разрыва плодной оболочки при недоношенной беременности и идиопатических самопроизвольных родов
Bussieres et al. Maternal prenatal stress and infant birth weight and gestational age: A meta-analysis of prospective studies
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
EA202090348A1 (ru) Способ неинвазивного пренатального выявления аномалий половых хромосом у плода и определения пола плода в случае одноплодной и двухплодной беременности
BR112014026440A2 (pt) assays, methods and apparatus for assessing rna disruption
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
MX2018015140A (es) Firmas de biomarcadores de lupus eritematoso sistemico y sus usos.
JP2019516104A5 (enExample)
Brady et al. Maternal serum alpha-fetoprotein levels peak at 19-21 weeks' gestation and subsequently decline in an NPHS1 sequence variant heterozygote; implications for prenatal diagnosis of congenital nephrosis of the Finnish type
CN109689890A (zh) 用于子宫腺肌症检测的生物标志物组合及其应用
Barr et al. National HIV transmission in 4–12 week olds in Malawi’s PMTCT option B+ program
Holden After Achilles
Reddy et al. Distribution of ABO and RH (D) blood groups in Motati Reddi of Kadapa District, Andhra Pradesh
Irving et al. After Achilles
Penney Fishing
JP2016531305A5 (enExample)
Li et al. Is it possible to use cell-free fetal DNA to perform prenatal tests for multiple pregnancies?
PL408305A1 (pl) Zastosowanie ceramidu C16 (C16-Cer) jako biomarkera w predykcji porodu przedwczesnego
FigueroaValverde et al. Prostate Cancer Trends in Southern Mexico: Statistical Data from 1978 to 2020
Marchili et al. One clinic’s experience with cell free fetal DNA testing in Argentina
Wang Response to" concerns about the statistical methodology described in the'clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors'"
WO2014191839A3 (en) Detection of gluten-specific t-cells
WO2015103664A8 (en) Risk stratification in influenza
UA91252U (uk) Спосіб прогнозування внутрішньоутробної інфекції плоду при недоношеній вагітності та передчасному розриві плодових оболонок